Market Overview:
The global aerosol delivery device market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in aerosol delivery devices. Based on type, the global aerosol delivery device market is segmented into dry powder inhalers (DPIs), metered dose inhalers (MDIs), and nebulizers. DPIs are further sub-segmented into breath-activated DPIs and manually operated DPIs. MDIs are further sub-segmented into pressurized MDI systems and non-pressurized MDI systems. Nebulizers are further sub-segmented into ultrasonic nebulizers and mesh nebulizers. Based on application, the global aerosol delivery device market is segmented into hospitals, clinics, drugstores, emergency centers, and others (including research institutes). Geographically, the global aerosol delivery device market is segmented into North America,, Latin America,, Europe,, Asia Pacific,, Middle East & Africa,. North America dominates the global Aerosols Delivery Device Market due to high prevalence of respiratory diseases such as asthma & COPD among people living in this region followed by Europe .
Product Definition:
Aerosol Delivery Device is a medical device used to deliver medication to the lungs in the form of an aerosol. It is important because it helps to improve the patient's breathing and overall health.
Dry Powder Inhaler:
Dry powder inhaler (DPI) is a device used to deliver dry powder medication via aerosol. It is an alternative to the liquid formulation of drugs and has been gaining importance in recent years owing to advantages such as easy handling, higher drug content per dose, and improved patient compliance.
The global DPI market was valued at USD 4.6 billion in 2015.
Metered Dose Inhaler:
Metered dose inhaler (MDI) is a type of inhalation aerosol device used to deliver medication. It consists of a metering valve, which delivers the dose by opening and closing automatically. The medicine is usually dispensed in the form of small particles called microparticles, which are too small for human lungs to absorb directly.
Application Insights:
Based on the application, the market is segmented into hospital, clinic, drugstore and emergency center. The hospital segment dominated the global aerosol delivery device market in 2017 owing to an increase in respiratory diseases and rising awareness about asthma among children. According to a study published by Global Asthma Report Card in 2019, around 40 million people suffer from asthma across the globe. In addition, increasing prevalence of chronic bronchitis along with other associated lung diseases such as emphysema will drive demand for inhalers over next few years.
The clinic segment is expected to witness lucrative growth during forecast period due to growing incidence of respiratory disorders coupled with high usage rates of metered dose inhalers and dry powder inhalers among patients suffering from asthma or COPD at clinics and hospitals worldwide.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, high healthcare expenditure, and increasing awareness about asthma management. Moreover, an increase in the prevalence of respiratory diseases is also expected to drive the demand for aerosol delivery devices over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years due to factors such as rising disposable income and improving healthcare infrastructure. In addition, a large population base suffering from chronic respiratory diseases such as asthma is also expected to drive regional growth during the forecast period. The Middle East & Africa region has one of lowest per capita incomes but highest disease burden in terms of Asthma among children under 5 years old globally (WHO). This can be attributed largely because dust particles are majorly responsible for triggering asthmatic reactions among individuals living in this region (Khalifa et al., 2016).
Growth Factors:
- Increasing demand for aerosol delivery devices in the pharmaceutical and medical industries for the treatment of various diseases.
- Growing demand for aerosol delivery devices from emerging economies due to increasing awareness about their benefits and rising disposable income levels.
- Technological advancements in aerosol delivery devices that offer better performance, accuracy, and safety features.
- Rising number of mergers and acquisitions among key players in the market to consolidate their positions and expand their product portfolios.
- Growing popularity of self-medication owing to busy lifestyles, which is driving the demand for portable aerosol delivery devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Aerosol Delivery Device Market Research Report
By Type
Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer
By Application
Hospital, Clinic, Drugstore, Emergency Center
By Companies
3M Company, Aerogen, Inc., Glaxosmithkline Plc, Johnson and Johnson, Koninklijke Philips N.V., Merck and Co. Inc., Metall Zug Group, Recipharm AB, Teva Pharmaceutical Industries Limited, Merxin Ltd, Gerresheimer AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Aerosol Delivery Device Market Report Segments:
The global Aerosol Delivery Device market is segmented on the basis of:
Types
Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Drugstore, Emergency Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M Company
- Aerogen, Inc.
- Glaxosmithkline Plc
- Johnson and Johnson
- Koninklijke Philips N.V.
- Merck and Co. Inc.
- Metall Zug Group
- Recipharm AB
- Teva Pharmaceutical Industries Limited
- Merxin Ltd
- Gerresheimer AG
Highlights of The Aerosol Delivery Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry Powder Inhaler
- Metered Dose Inhaler
- Nebulizer
- By Application:
- Hospital
- Clinic
- Drugstore
- Emergency Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aerosol Delivery Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aerosol delivery devices are devices that use pressurized gas to dispense a liquid, powder, or other substance.
Some of the major players in the aerosol delivery device market are 3M Company, Aerogen, Inc., Glaxosmithkline Plc, Johnson and Johnson, Koninklijke Philips N.V., Merck and Co. Inc., Metall Zug Group, Recipharm AB, Teva Pharmaceutical Industries Limited, Merxin Ltd, Gerresheimer AG.
The aerosol delivery device market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aerosol Delivery Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aerosol Delivery Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aerosol Delivery Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aerosol Delivery Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aerosol Delivery Device Market Size & Forecast, 2018-2028
4.5.1 Aerosol Delivery Device Market Size and Y-o-Y Growth
4.5.2 Aerosol Delivery Device Market Absolute $ Opportunity
Chapter 5 Global Aerosol Delivery Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Aerosol Delivery Device Market Size Forecast by Type
5.2.1 Dry Powder Inhaler
5.2.2 Metered Dose Inhaler
5.2.3 Nebulizer
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Aerosol Delivery Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Aerosol Delivery Device Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Drugstore
6.2.4 Emergency Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aerosol Delivery Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aerosol Delivery Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Aerosol Delivery Device Analysis and Forecast
9.1 Introduction
9.2 North America Aerosol Delivery Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Aerosol Delivery Device Market Size Forecast by Type
9.6.1 Dry Powder Inhaler
9.6.2 Metered Dose Inhaler
9.6.3 Nebulizer
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Aerosol Delivery Device Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Drugstore
9.10.4 Emergency Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Aerosol Delivery Device Analysis and Forecast
10.1 Introduction
10.2 Europe Aerosol Delivery Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Aerosol Delivery Device Market Size Forecast by Type
10.6.1 Dry Powder Inhaler
10.6.2 Metered Dose Inhaler
10.6.3 Nebulizer
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Aerosol Delivery Device Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Drugstore
10.10.4 Emergency Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Aerosol Delivery Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Aerosol Delivery Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Aerosol Delivery Device Market Size Forecast by Type
11.6.1 Dry Powder Inhaler
11.6.2 Metered Dose Inhaler
11.6.3 Nebulizer
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Aerosol Delivery Device Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Drugstore
11.10.4 Emergency Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Aerosol Delivery Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Aerosol Delivery Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Aerosol Delivery Device Market Size Forecast by Type
12.6.1 Dry Powder Inhaler
12.6.2 Metered Dose Inhaler
12.6.3 Nebulizer
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Aerosol Delivery Device Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Drugstore
12.10.4 Emergency Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Aerosol Delivery Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Aerosol Delivery Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Aerosol Delivery Device Market Size Forecast by Type
13.6.1 Dry Powder Inhaler
13.6.2 Metered Dose Inhaler
13.6.3 Nebulizer
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Aerosol Delivery Device Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Drugstore
13.10.4 Emergency Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aerosol Delivery Device Market: Competitive Dashboard
14.2 Global Aerosol Delivery Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3M Company
14.3.2 Aerogen, Inc.
14.3.3 Glaxosmithkline Plc
14.3.4 Johnson and Johnson
14.3.5 Koninklijke Philips N.V.
14.3.6 Merck and Co. Inc.
14.3.7 Metall Zug Group
14.3.8 Recipharm AB
14.3.9 Teva Pharmaceutical Industries Limited
14.3.10 Merxin Ltd
14.3.11 Gerresheimer AG
